SELLAS Life Sciences (SLS) Leases (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Leases for 6 consecutive years, with $513000.0 as the latest value for Q3 2024.
- Quarterly Leases fell 13.34% to $513000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $513000.0 through Sep 2024, down 13.34% year-over-year, with the annual reading at $858000.0 for FY2023, 1.83% down from the prior year.
- Leases for Q3 2024 was $513000.0 at SELLAS Life Sciences, down from $633000.0 in the prior quarter.
- The five-year high for Leases was $1.1 million in Q1 2022, with the low at $123000.0 in Q1 2020.
- Average Leases over 5 years is $784736.8, with a median of $812000.0 recorded in 2021.
- The sharpest move saw Leases crashed 73.89% in 2020, then surged 594.31% in 2021.
- Over 5 years, Leases stood at $896000.0 in 2020, then dropped by 19.31% to $723000.0 in 2021, then grew by 20.89% to $874000.0 in 2022, then fell by 1.83% to $858000.0 in 2023, then crashed by 40.21% to $513000.0 in 2024.
- According to Business Quant data, Leases over the past three periods came in at $513000.0, $633000.0, and $747000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.